The dilemma of implantable cardioverter-defibrillator therapy in the geriatric population

Journal of Geriatric Cardiology

Volumn 8, Issue 3, 2011, Pages 195-200

  Revenco, Diana ^a   Morgan, James P ^a   Tsao, Lana ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Geriatric population; Heart failure; ICD therapy

Indexed keywords

AMIODARONE; ANXIOLYTIC AGENT; AZIMILIDE; PROPOFOL; SOTALOL;

AGE; CARDIOGENIC SHOCK; CLINICAL DECISION MAKING; CONFERENCE PAPER; CONVULSIVE THERAPY; DEFIBRILLATOR; DEVICE REMOVAL; ELECTROCARDIOGRAM; FOLLOW UP; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; LUNG TOXICITY; MONOTHERAPY; QRS COMPLEX; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; SUDDEN DEATH; TERMINAL CARE; THORAX RADIOGRAPHY; UREA NITROGEN BLOOD LEVEL;

EID: 80053541892     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1263.2011.00195     Document Type: Conference Paper

References (18)

1. Schocken DD, Benjamin EJ, Fonarow GC, et al. Prevention of heart failure: A scientific statement from the American Heart Association Councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group. Circulation 2008; 117: 2544-2565. (Pubitemid 351670463)
2. McCullough PA, Philbin EF, Spertus JA, et al. Confirmation of a heart failure epidemic: Findings from the resource utilization among congestive heart failure (REACH) study. J Am Coll Cardiol 2002; 39: 60-69. (Pubitemid 34059862)
3. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011; 8: 30-41.
4. Epstein AE, Kay GN, Plumb VJ et al. Implantable cardioverter - defibrillator prescription in elderly. Heart Rhythm 2009; 6: 1136-1139.
5. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883. (Pubitemid 34984635)
6. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237. (Pubitemid 40110811)
7. Healey JS, Hallstrom AP, Kuck KH, et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J 2007; 28: 1746-1749. (Pubitemid 47227082)
8. Swindle JP, Rich MW, McCann P, et al. Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch Intern Med 2010; 170: 631-637.
9. Moss AJ, Greenberg H, Case RB, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrilator. Circulation 2004; 110: 3760-3765. (Pubitemid 40023973)
10. Schaer B, Kuhne M, Koller MT, et al. Therapy with implantable cardioverter defibrillator in patients with coronary artery disease and dilated cardiomyopathy: benefits and disadvantages. Swiss Med Weekly 2009; 139: 647-653.
11. Wathen MS, DeGroot PJ, Sweeney MO et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004; 110: 1591-1596.
12. Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA 2006; 295: 165-168.
13. Aliot EM, Stevenson WG, Almendral JM, et al. EHRA/HRS expert consensus on catheter ablation of ventricular arhythmias. Heart Rhythm 2009; 6: 886-933.
14. Brodine WN, Tung RT, Lee JK, et al. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the MADIT-II). Am J Cardiol 2005; 96: 691-695. (Pubitemid 41207315)
15. Goldstein NE, Lampert R, Bradley E, et al. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004; 141: 835-838. (Pubitemid 39601176)
16. Goldstein NE, Mehta D, Siddiqui S, et al. "That's like an act of suicide" patient's attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2007; 23: 7-12. (Pubitemid 350295388)
17. Lampert R, Hayes DL, Annas GJ, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIED) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010; 7: 1008-1026.
18. Lindsay BD, Estes NA, Maloney JD, et al. Heart rhythm society policy statement update: recommendations on the role of industry employed allied professionals. Heart Rhythm 2008; 5: 8-10.